Vanta Bioscience Ltd vs Vimta Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Vanta Bioscience Ltd is ₹ 20.4 as of 16 Oct 15:30 . The P/E Ratio of Vanta Bioscience Ltd changed from 229.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Vimta Labs Ltd changed from 16.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Vanta Bioscience Ltd changed from ₹ 102.89 crore on March 2021 to ₹ 13.96 crore on March 2025 . This represents a CAGR of -32.93% over 5 yearsThe Market Cap of Vimta Labs Ltd changed from ₹ 355.7 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The Revenue of Vanta Bioscience Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Vimta Labs Ltd is ₹ 75.57 crore as of Jun '24 . The EBITDA of Vanta Bioscience Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Vimta Labs Ltd is ₹ 25 crore as of Jun '24 . The Net Profit of Vanta Bioscience Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Vimta Labs Ltd is ₹ 12.28 crore as of Jun '24 . The Dividend Payout of Vanta Bioscience Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Vimta Labs Ltd changed from 20.79 % on March 2021 to 11.52 % on March 2026 . This represents a CAGR of -9.37% over 6 years .

About Vanta Bioscience Ltd

Vanta Bioscience Limited (VBS) was originally incorporated as a Private Limited Company on 29th April 2016 and was converted into a Public Limited Company with effect from 17th March 2017. VBS is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition, Company provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product.
It also provides expert services for determination of health based exposure limits (e.

About Vimta Labs Ltd

Vimta Labs Limited., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries.
Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.

FAQs for the comparison of Vanta Bioscience Ltd and Vimta Labs Ltd

Which company has a larger market capitalization, Vanta Bioscience Ltd or Vimta Labs Ltd?

Market cap of Vanta Bioscience Ltd is 14 Cr while Market cap of Vimta Labs Ltd is 2,096 Cr

What are the key factors driving the stock performance of Vanta Bioscience Ltd and Vimta Labs Ltd?

The stock performance of Vanta Bioscience Ltd and Vimta Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Vanta Bioscience Ltd and Vimta Labs Ltd?

As of October 24, 2026, the Vanta Bioscience Ltd stock price is INR ₹20.4. On the other hand, Vimta Labs Ltd stock price is INR ₹468.95.

How do dividend payouts of Vanta Bioscience Ltd and Vimta Labs Ltd compare?

To compare the dividend payouts of Vanta Bioscience Ltd and Vimta Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.